Targeted therapy of multiple myeloma
Multiple myeloma (MM) is a malignant proliferative disease of monoclonal plasma cells (PCs) and is characterized by uncontrolled proliferation of PCs and excessive production of specific types of immunoglobulins. Since PCs are terminally differentiated B cells, the World Health Organization (WHO) cl...
Enregistré dans:
Auteurs principaux: | Shan Zhou, Renxi Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Open Exploration Publishing Inc.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/52c45691c8d9471199f1baa11f339240 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Multiple myeloma
par: Larisa P. Mendeleeva, et autres
Publié: (2021) -
IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
par: E. A. Senkina, et autres
Publié: (2014) -
Development and validation of an expanded targeted sequencing panel for non-invasive prenatal diagnosis of sporadic skeletal dysplasia
par: Ching-Yuan Wang, et autres
Publié: (2021) -
Incidence, etiology, and course of hypercalcemia-induced AKI in a tertiary care center from northern India
par: Nucksheeba Aziz Bhat, et autres
Publié: (2021) -
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
par: Kim De Veirman, et autres
Publié: (2021)